AI for Pipeline Prioritization & Resource Allocation
What you'll learn
- 1Apply AI to multi-criteria portfolio optimization that balances risk, reward, and strategic fit
- 2Use AI to model resource constraints and identify optimal allocation across the pipeline
- 3Build decision frameworks that incorporate both quantitative AI analysis and qualitative strategic factors
- 4Design portfolio review processes that leverage AI analytics for governance committees
# AI for Pipeline Prioritization & Resource Allocation
A pharmaceutical R&D portfolio typically contains 20-50 programs across preclinical through Phase 3 development. Each program competes for limited resources: capital, clinical operations capacity, manufacturing development slots, regulatory affairs bandwidth, and management attention. Portfolio prioritization determines which programs get funded, which get delayed, and which get terminated.
The Portfolio Optimization Challenge
Traditional portfolio reviews suffer from several problems: - Advocacy bias — Each program's champion presents the most optimistic case - Sunk cost fallacy — Reluctance to terminate programs with significant prior investment - Recency bias — Programs with recent positive data get disproportionate attention - Siloed evaluation — Each program is evaluated independently rather than as part of a portfolio - Resource constraints ignored — Prioritization happens before resource feasibility is checked
AI-powered portfolio optimization addresses these by evaluating all programs simultaneously within explicit resource constraints.
Unlock this lesson
Upgrade to Pro to access the full content
What you'll learn:
- Apply AI to multi-criteria portfolio optimization that balances risk, reward, and strategic fit
- Use AI to model resource constraints and identify optimal allocation across the pipeline
- Build decision frameworks that incorporate both quantitative AI analysis and qualitative strategic factors